Clinical Trials on Prostate Carcinoma in New Zealand
Total 5171 results
-
Antisoma ResearchCompletedProstate CancerUnited States
-
Boston Scientific CorporationAugmenix, Inc.Completed
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); Gilead SciencesActive, not recruiting
-
Ryan J. HalterDartmouth CollegeRecruitingProstate CancerUnited States
-
Hackensack Meridian HealthRecruitingProstate CancerUnited States
-
University of RochesterRoswell Park Cancer InstituteRecruiting
-
Xavier University of Louisiana.Tulane UniversityCompletedProstate CancerUnited States
-
University of New MexicoWithdrawn
-
St Vincent's Hospital, SydneyClarity Pharmaceuticals LtdCompleted
-
Albert Einstein College of MedicineActive, not recruiting
-
ExelixisCompletedPain | Prostatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerBelgium, France, Italy, Canada, United States, Germany, United Kingdom, Australia, Netherlands, Spain, Austria, Ireland, Puerto Rico, Sweden
-
Ferring PharmaceuticalsCompleted
-
IsoRay Medical, Inc.Swedish Medical CenterWithdrawn
-
Blue Earth Therapeutics LtdPSI CRORecruitingUrogenital Neoplasms | Prostatic Neoplasms | Prostatic Diseases | Prostate Cancer | Metastatic Castration-resistant Prostate Cancer | mCRPCUnited States, Netherlands
-
Molecular Insight Pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
Melanoma and Skin Cancer Trials LimitedRecruitingNeuroendocrine Tumors | Merkel Cell Carcinoma | Merkel Cell Carcinoma, Stage I | Merkel Cell Carcinoma, Stage II | Merkel Cell Carcinoma, Stage III | Carcinoma Neuroendocrine SkinAustralia, New Zealand
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
SanofiCompletedProstate Cancer MetastaticAustralia, Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Finland, Hungary, India, Ireland, Italy, Kazakhstan, Luxembourg, Malaysia, Mexico, Philippines, Poland, Portugal, Romania, Serbia, Singapo... and more
-
Molecular Insight Pharmaceuticals, Inc.CompletedProstate CancerUnited States, Canada
-
University of Texas Southwestern Medical CenterBoston Scientific CorporationActive, not recruitingProstate Cancer AdenocarcinomaUnited States
-
Orion Corporation, Orion PharmaEndo PharmaceuticalsCompletedProstate CancerUnited States, United Kingdom, Finland, France, Czech Republic, Estonia
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsActive, not recruitingProstate CancerUnited States
-
NYU Langone HealthCompleted
-
Orion Corporation, Orion PharmaActive, not recruitingProstate Cancer MetastaticFrance, United Kingdom, Finland, United States
-
NYU Langone HealthCompletedProstate Cancer | Bladder CancerUnited States
-
Millennium Pharmaceuticals, Inc.CompletedProstate CancerUnited States, Canada
-
Veru Inc.TerminatedMetastatic Castration Resistant Prostate CancerUnited States
-
Millennium Pharmaceuticals, Inc.CompletedProstate CancerFrance, United States, Belgium, Spain, Australia, Canada, Netherlands, Italy, Poland, Czechia, Estonia, Finland, Hungary, Greece
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.Active, not recruitingProstate Cancer | Cancer of the Prostate | Nonmetastatic Castration-Resistant Prostate CancerHong Kong, Canada, China, Germany, Spain, Netherlands, United Kingdom, Korea, Republic of, Taiwan, Australia, Denmark, France, United States, Singapore, Poland, Malaysia, Turkey, Belgium, Argentina, Thailand, Slovakia, Brazil, Finland, Ita... and more
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)CompletedProstate Cancer | OsteoporosisUnited States
-
BayerActive, not recruitingMetastatic Hormone-sensitive Prostate CancerUnited States
-
Inovio PharmaceuticalsCompletedProstate CancerUnited States
-
DendreonCompletedProstate CancerUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)CompletedProstate AdenocarcinomaUnited States
-
Weill Medical College of Cornell UniversityProgenics Pharmaceuticals, Inc.; Viewray Inc.RecruitingProstate CancerUnited States, United Kingdom
-
University of RochesterCompletedProstate CancerUnited States
-
Myovant Sciences GmbHCompletedA Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer (HERO)Prostate CancerUnited States, Germany, Spain, New Zealand, Brazil, Belgium, Australia, Austria, Canada, China, Denmark, Finland, France, Italy, Japan, Korea, Republic of, Netherlands, Poland, Slovakia, Sweden, Taiwan, United Kingdom
-
Royal North Shore HospitalRecruitingProstate CancerAustralia
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Columbia University; NYU Langone Health; Weill... and other collaboratorsActive, not recruiting
-
Weill Medical College of Cornell UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedMetastatic Prostate AdenocarcinomaUnited States
-
AstraZenecaCompletedMetastatic Castrate-Resistant Prostate Cancer (mCRPC), | Efficacy, | Safety and Tolerability, | Pharmacokinetics, | Pharmacodynamics, | Tumour Response.United Kingdom, United States
-
Medi-Tate Ltd.CompletedBenign Prostate HyperplasiaUnited States, Canada
-
Memorial Sloan Kettering Cancer CenterFerring Pharmaceuticals; University of Michigan; University of Texas Southwestern...Completed
-
BIND TherapeuticsCompleted
-
Montefiore Medical CenterAlbert Einstein College of MedicineActive, not recruitingProstate CancerUnited States
-
NYU Langone HealthBlue Earth DiagnosticsRecruitingProstate CancerUnited States
-
Columbia UniversityTerminatedProstate Cancer | Nerve Sparing ProstatectomyUnited States